![PRESS RELEASE: Sanofi Partnering With Leading Academic Cooperative Groups To Study Amcenestrant In The Adjuvant Setting For Patients With Estrogen Receptor Positive Breast Cancer 2022 - EORTC PRESS RELEASE: Sanofi Partnering With Leading Academic Cooperative Groups To Study Amcenestrant In The Adjuvant Setting For Patients With Estrogen Receptor Positive Breast Cancer 2022 - EORTC](http://www.eortc.org/app/uploads/2021/06/Sanofi_press-release.jpg)
PRESS RELEASE: Sanofi Partnering With Leading Academic Cooperative Groups To Study Amcenestrant In The Adjuvant Setting For Patients With Estrogen Receptor Positive Breast Cancer 2022 - EORTC
Sally Bain - Senior Director, Global Media Relations at Sanofi - Cambridge, Massachusetts, United States | LinkedIn
Sally Bain - Senior Director, Global Media Relations at Sanofi - Cambridge, Massachusetts, United States | LinkedIn
Sally Bain - Senior Director, Global Media Relations at Sanofi - Cambridge, Massachusetts, United States | LinkedIn
![PRESS RELEASE: Sanofi Partnering With Leading Academic Cooperative Groups To Study Amcenestrant In The Adjuvant Setting For Patients With Estrogen Receptor Positive Breast Cancer 2022 - EORTC PRESS RELEASE: Sanofi Partnering With Leading Academic Cooperative Groups To Study Amcenestrant In The Adjuvant Setting For Patients With Estrogen Receptor Positive Breast Cancer 2022 - EORTC](https://www.eortc.org/app/uploads/2021/06/Ameera-study_EORTC-Sanofi-BIG-AFT.jpg)